Sale!

BMPR1A Gene Polyposis Syndrome Hereditary Mixed Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The BMPR1A Gene Polyposis Syndrome Hereditary Mixed Type 2 Genetic Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the BMPR1A gene. These mutations are linked to Hereditary Mixed Polyposis Syndrome Type 2 (HMPS2), a rare condition that predisposes individuals to developing multiple polyps in the gastrointestinal tract. These polyps have the potential to become cancerous if left undetected and untreated. The condition follows an autosomal dominant inheritance pattern, meaning a mutation in just one of the two copies of the gene can lead to the syndrome.

The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing technologies to detect any abnormalities in the BMPR1A gene. The result from this test can provide crucial information for individuals with a family history of polyposis syndromes or early-onset colorectal cancer, enabling them to make informed decisions about their health management.

Early detection through genetic testing like the BMPR1A Gene Polyposis Syndrome Hereditary Mixed Type 2 Genetic Test allows for timely surveillance and intervention, significantly reducing the risk of developing colorectal cancer associated with the syndrome. Furthermore, it can guide genetic counseling and testing for family members who may also be at risk.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BMPR1A Gene Polyposis Syndrome Hereditary Mixed Type 2 Genetic Test

Components: BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 NGS Genetic DNA Test gene BMPR1A

Test Details: BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 is a genetic disorder characterized by the development of multiple polyps in the colon and rectum. It is caused by mutations in the BMPR1A gene, which is involved in the regulation of cell growth and division. NGS Genetic Test refers to Next-Generation Sequencing Genetic Test, which is a high-throughput sequencing technology used to analyze multiple genes simultaneously. In the context of BMPR1A Gene Polyposis syndrome, hereditary mixed type 2, NGS Genetic Test can be used to identify mutations in the BMPR1A gene that are associated with the disorder. The NGS Genetic Test involves sequencing the DNA of an individual to identify any genetic variations or mutations in the BMPR1A gene. This can help in confirming a diagnosis of BMPR1A Gene Polyposis syndrome and provide information about the specific mutation present in the individual. Genetic testing for BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 can be useful for individuals with a family history of the disorder or those who exhibit symptoms of the condition. It can help in early detection, risk assessment, and management of the disorder. Additionally, genetic testing can also be used for carrier screening and prenatal diagnosis in families with a known BMPR1A gene mutation. It is important to note that genetic testing should be done under the guidance of a healthcare professional or a genetic counselor who can provide appropriate counseling and interpretation of the results.

Test Name BMPR1A Gene Polyposis syndrome hereditary mixed type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 NGS Genetic DNA Test gene BMPR1A
Test Details

BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 is a genetic disorder characterized by the development of multiple polyps in the colon and rectum. It is caused by mutations in the BMPR1A gene, which is involved in the regulation of cell growth and division.

NGS Genetic Test refers to Next-Generation Sequencing Genetic Test, which is a high-throughput sequencing technology used to analyze multiple genes simultaneously. In the context of BMPR1A Gene Polyposis syndrome, hereditary mixed type 2, NGS Genetic Test can be used to identify mutations in the BMPR1A gene that are associated with the disorder.

The NGS Genetic Test involves sequencing the DNA of an individual to identify any genetic variations or mutations in the BMPR1A gene. This can help in confirming a diagnosis of BMPR1A Gene Polyposis syndrome and provide information about the specific mutation present in the individual.

Genetic testing for BMPR1A Gene Polyposis syndrome, hereditary mixed type 2 can be useful for individuals with a family history of the disorder or those who exhibit symptoms of the condition. It can help in early detection, risk assessment, and management of the disorder. Additionally, genetic testing can also be used for carrier screening and prenatal diagnosis in families with a known BMPR1A gene mutation.

It is important to note that genetic testing should be done under the guidance of a healthcare professional or a genetic counselor who can provide appropriate counseling and interpretation of the results.